I think it’s genetic ACM because of the pattern of LGE involvement. There is circumferential LGE (the "ring sign") with lateral wall predominance vs. septal (unlike in cardiac sarcoidosis).
The lateral wall involvement spares the most subendocardial portion and/or the papillary muscles and trabeculations, indicating it is subepicardial (unlike a transmural MI that started subendocardially and involves the papillary muscles/trabeculations).
In the septum, the LGE spares the very RV side of the septum (also a distinguishing feature from cardiac sarcoidosis) and is therefore often midmyocardial… the ring is subepicardial laterally and midmyocardial septally.
Elevated T1/T2 indicates an acute process (myocarditis), but it does not indicate the *cause*. We know ACM can present with acute myocarditis... this is one recent study: ahajournals.org/doi/full/10.11…
The fact that genetic ACM can present with myocarditis is not new... it has been described for 15-20 years. For example, here’s a sentence from a 2008 paper from the legendary Bill McKenna: sciencedirect.com/science/articl…
Resolution of LGE does not tell us the cause of the myocarditis… it is simply a function of the extent of acute injury. Acute injury of a smaller extent can heal and become undetectable by LGE (= the scar is under the threshold of detection).
Bottomline – a diagnosis of myocarditis (like a diagnosis of NICM) is not wrong, but it’s incomplete. Not all myocarditis is viral.
We have a growing database of ACM cases, some with myocarditis... we hope to publish our experience at some point.
• • •
Missing some Tweet in this thread? You can try to
force a refresh
First, was the LGE in this study an artifact ("overcalling")?
No, because:
- This paper comes from pioneers and some of the biggest names in CMR
- Our anecdotal experience matches these findings
- The images in the paper very clearly demonstrate LGE.
A CMR 4 months later showed a near resolution of the anteroseptal/anterior/anterolateral LGE (red arrows). The inferior LGE (blue arrow) that did not disappear matched the fat seen on cine images.
It’s been over 2 months since the first descriptions of cardiac manifestations of Covid-19. There have been many papers and reviews on this topic. What have we learned about how SARS-CoV-2 can affect the heart? #whyCMR#cardiotwitter
Troponin elevations and low EFs are frequently described. Why do they happen? Most papers use the term Covid-19 myocarditis. But can SARS-CoV-2 cause fulminant myocarditis (= extensive focal myocardial necrosis, as seen with viral lymphocytic or giant cell myocarditis)?
I tried looking at published CMR images and autopsy studies to get some insights into what happens in the hearts of Covid-19 patients. I’ll share my thoughts on 10 papers with CMR images and 2 papers each with autopsy data in >10 patients:
Here’s an interesting paper published in JACC yesterday. The investigators studied 187 acute myocarditis patients with CMR (within a week) and repeated the CMR at 6 months. onlinejacc.org/content/74/20/…
They found that LGE was present in 96% at the initial presentation and 86% at 6 months. They conclude:
“In the acute setting, LGE does not mean definite fibrosis, and it may disappear at 6 months.”
In the main text, they elaborate:
“Our data demonstrated that LGE in the acute phase of myocarditis is not necessarily synonymous with irreversible damage, because in 11% of our patients, LGE completely disappeared at follow-up.”
With all the discussion about viability in the past few days, I would like to share how I interpret and report viability on CMR. I first look for LGE. Rarely, there’s no LGE and it’s all viable or more likely, a non-ischemic cardiomyopathy. #WhyCMR 1/18
When I see LGE, I confirm it’s in an ischemic pattern – subendocardial or transmural, and limited to a coronary territory, i.e., an MI. If not, it's again a non-ischemic cardiomyopathy and not a viability issue anymore. 2/18
Next, I try to identify how many and where the MIs are. For this, I look at the extent and locations of ischemic LGE and decide which of the 17 LV segments are likely to be supplied by each of the coronary arteries. 3/18